Table 1

Characteristics of Hospitalized Pediatric Patients With COVID-19

Characteristic (N = 22)No.%
Sex
 Male1255
 Female1045
Age, y
 Distribution
  <11045
  1–6418
  7–12314
  13–18523
Presenting symptoms
 Fever1568
 Any respiratory symptom941
  Difficulty breathing627
  Nasal congestion523
  Cough418
 Fatigue627
 Seizures29
 Headache14
Duration of symptoms before admission, d
 Asymptomatic29
  <1314
  1–31359
  >3418
Known COVID-19 contact
 At home314
 Outside of home314
 None known1672
Underlying medical conditions627
Other admitting diagnosis and COVID-19 positivity732
Respiratory support
 Noninvasive ventilation314
 Mechanical ventilation418
 None1568
Viral coinfection/total tested2/729
Chest radiograph abnormalities/total imaged5/1145
Laboratory abnormalities/total tested
 CRP >1 mg/L8/1080a
 Procalcitonin > 0.5 ng/mL6/786b
 Absolute lymphocytes <1500/μL7/2232
 Transaminitis2/729
  • Underlying medical conditions were as follows: malignancy, 3; bronchiectasis, 1; cardiac (patent ductus arteriosus–closed ventricular septal defect), 1; prematurity or chronic lung disease, 1. Other admitting diagnoses were 1 each of perforated appendix, urinary tract infection, cellulitis, septic arthritis, cardiac arrest, purulent otorrhea, and myositis. Patients also tested positive for SARS-CoV-2. Viral coinfection indicates positive for enterovirus/rhinovirus. Respiratory support (noninvasive ventilation) includes nasal canula, high flow oxygen, and bilevel positive airway pressure.

  • a 4 of 8 with codiagnoses.

  • b 3 of 7 with underlying medical condition.